Clozapine RE(MS)defined: Enhancing Psychiatric Pharmacy Practice with Therapeutic Drug Monitoring and Updated Guidelines
First presented in April 2025 at the AAPP 2025 Annual Meeting
Description:
This workshop will explore the pending changes in Clozapine REMS, providing psychiatric pharmacists with essential knowledge on the appropriate use of clozapine and the critical role of therapeutic drug monitoring (TOM) in optimizing patient outcomes. Participants will gain practical insights into navigating regulatory updates and enhancing clinical decision-making.
Presenting Faculty:
Megan Ehret, PharmD, MS, BCPP, FAAPP
- Professor
- Co-Director of Mental Health Program
- Vice-Chair of Academic Affairs
- Department of Practice, Sciences, and Health Outcomes Research
- University of Maryland School of Pharmacy
Deanna L. Kelly, PharmD, BCPP
- Dr. William and Carol Carpenter Professor in Psychiatry for Mental Illness Research
- Acting Director, Maryland Psychiatric Research Center
- Chief, Treatment Research Program (TRP)
- University of Maryland School of Medicine
Robert O. Cotes, MD, DFAPA
- Professor and Distinguished Physician
- Co-Director, Clinical & Research Program for Psychosis at Grady Health System
- Department of Psychiatry and Behavioral Sciences
- Emory University School of Medicine
- Editor-In-Chief, Community Mental Health Journal
Additional Resources:
For additional handouts, questions, or inquiries, please contact hello@saladax.com or enter your email below!
